Stock screenerAll disclosures →
EDGAR →
CELC
Conviction 12HealthcareScan · Mon, Aug 10, 2026CELC$90.78-2.16%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.07M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price90.78
Change-2.16%
Gap+1.02%
Rel volume0.55×
Avg volume1.68M
Avg $ vol151.13M
SMA 2089.60
SMA 5095.13
SMA 200104.79
Price vs 50-4.58%
Price vs 200-13.37%
MA stackbearish
50/200 crossdeath · 8d
Supertrenddown · 100.04
RSI (14)47
MACD hist1.15
MACD crossbull · 4d
Stoch %K / %D73 / 82
ADX (14)18
+DI / −DI19 / 22
RSI divergence—
MACD divergence—
ATR %+6.00%
ADR %5.88%
52w high144.98
52w low45.22
From 52w high-37.38%
Above 52w low+100.75%
New 52w highNo
SqueezeOff
Bollinger width27.00%
%B0.55
Donchian pos34.67%
Donchian high113.73
Donchian low78.60
AVWAP (52w high)102.64
vs AVWAP high-11.55%
AVWAP (52w low)92.45
vs AVWAP low-1.81%
OBV trendDown
Chaikin MF (20)0.03
Today vs 20d0.55×
Avg vol (14d)1.07M
Avg vol (20d)1.68M
Avg $ vol (20d)151.13M
Market cap4.43B
RS 3m (vs SPY)-34.72%
RS 6m (vs SPY)-25.14%
RS line new highNo
Trend template3/8
Technical rank17.4
1 week+3.49%
1 month-15.62%
3 months-30.73%
6 months-14.96%
1 year+105.20%
YTD-9.72%
P/E-25.01
P/B82.71
P/S—
P/FCF-28.84
EPS-3.79
Div yield—
ROE-330.77%
ROA-43.16%
Debt/Eq2.58
Current12.31
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-58.39%
Price target165.00
Target upside81.76%
Analyst ratingBuy
Institutional107.54%
Ent. value4.42B
Revenue—
Net income-52.84M
Gross profit—
Free cash flow-153.53M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out48.77M
Employees155
ListedWed, Sep 20, 2017
Free float34.78M
Float %75.2%
Short interest11.15M
Days to cover5.7d
Short volume51.1%
Squeeze score72 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.97 vs −$1.07
Last surprise+9.3% beat
Setup gradeD
Conviction12 / 100
Pattern quality—
Tech rank17.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance115.47
Support80.58
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CELC
No recent disclosed trades by Congress in CELC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CELC · 6 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP Insider · Common Stock · 2026-07-14 | Sell | 261.37K | $27M | 2026-07-14 | 2026-07-16 |
BAKER BROS. ADVISORS LP Insider · Common Stock · 2026-07-14 | Sell | 2.84M | $291M | 2026-07-14 | 2026-07-16 |
Murphy Polly A. Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Furcht Leo Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
ROMP CHARLES R Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Buller Richard E Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Buller Richard E Director · Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
NIGON RICHARD Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Dalvey David Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Dalvey David Director · Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in CELC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.